Bone Marrow TransplantationTransplantation, AutologousHematopoietic Stem Cell TransplantationTransplantation, HomologousBone MarrowBone Marrow CellsPeripheral Blood Stem Cell TransplantationTransplantation ConditioningStem CellsGraft vs Host DiseaseGraft SurvivalCyclophosphamideCombined Modality TherapyHematopoietic Stem CellsHematopoietic Stem Cell MobilizationWhole-Body IrradiationBone and BonesAntigens, CD34Multiple MyelomaEtoposideStem Cell TransplantationAnemia, AplasticGranulocyte Colony-Stimulating FactorLeukemiaAntineoplastic Combined Chemotherapy ProtocolsTransplantation ChimeraTreatment OutcomeLiver TransplantationTissue DonorsBusulfanBone Marrow PurgingHistocompatibility TestingHistocompatibilityHematopoiesisTransplantation, IsogeneicMice, Inbred C57BLBone Marrow DiseasesCell DifferentiationKidney TransplantationRecurrenceRadiation ChimeraLeukemia, Myelogenous, Chronic, BCR-ABL PositiveTime FactorsLeukemia, Myeloid, AcuteEmbryonic Stem CellsHematologic NeoplasmsBone Marrow ExaminationImmunosuppressive AgentsRemission InductionAdult Stem CellsGraft RejectionPrecursor Cell Lymphoblastic Leukemia-LymphomaHepatic Veno-Occlusive DiseaseColony-Forming Units AssayBone RemodelingTransplantation ImmunologyLeukemia, MyeloidBone Marrow NeoplasmsT-LymphocytesGraft vs Host ReactionLymphocyte DepletionCells, CulturedImmunosuppressionMesenchymal Stem Cell TransplantationLymphoma, Non-HodgkinAcute DiseaseChimeraLeukocyte TransfusionHeart TransplantationSevere Combined ImmunodeficiencyFlow CytometrySurvival AnalysisMyelodysplastic SyndromesHLA AntigensRetrospective StudiesPluripotent Stem CellsStem Cell NicheHematologic DiseasesCell LineageMesenchymal Stromal CellsLung TransplantationLymphocyte TransfusionCyclosporineBone DensityActuarial AnalysisCell SeparationLeukocyte CountCarmustineNuclear FamilyFollow-Up StudiesStem Cell FactorSpleenPancytopeniaGraft vs Tumor EffectGraft vs Leukemia EffectSurvival RateMice, Inbred BALB CCytarabineOrgan TransplantationMelphalan